Press Releases

Media Contact: Michelle Kirkwood, Director, Strategic Communications and Media Relations, press@diabetes.org

The most recent press releases from the American Diabetes Association:

September 25, 2017
American Diabetes Association Urges Senators to Oppose Graham-Cassidy Repeal Bill and Continue Working on Bipartisan Health Care Legislation
Standing for more than 114 million Americans living with or at risk for diabetes, the American Diabetes Association urges the United States Senate to reject the Graham-Cassidy proposal to repeal the Affordable Care Act (ACA).

September 15, 2017
Diabetes Emergency Relief Coalition Continues to Support Areas Impacted by Hurricanes Harvey and Irma with Critical Diabetes Supplies
Convened by the American Diabetes Association (ADA), a coalition of eight leading diabetes care and research organizations continue, through their Diabetes Emergency Relief Coalition (DERC), to help provide critical diabetes supplies to regions impacted by Hurricanes Harvey and Irma

September 8, 2017
Diabetes Coalition Continues to Support Southeast Texas with Critical Diabetes Supplies and Ready to Respond to Hurricane Irma’s Impact in Puerto Rico and Florida
Convened by the ADA, a coalition of seven leading diabetes care and research organizations have formed a strong Diabetes Emergency Relief Coalition (DERC) to help provide critical diabetes supplies to regions impacted by Hurricanes Harvey and Irma.

September 7, 2017
American Diabetes Association Partners with Children's Hospital Los Angeles to Address Growing Populations with Type 2 Diabetes
Association and Children’s Hospital Los Angeles (CHLA) Diabetes & Obesity Program have joined forces to address the growing incidence of type 2 diabetes among children and adolescents through a dedicated education program called Camp PowerUp.

September 2, 2017
Update: Diabetes Care and Supplies Available in Houston and San Antonio, Plus Extended Hours at 1-800-DIABETES Call Center
The first shipment of more than 3,750 pounds of diabetes supplies provided by the critical partnership of ADA, JDRF, Insulin for Life (IFL USA) and the Endocrine Society arrived in the Houston area early this morning.

September 1, 2017
Free Diabetes Supplies Available Tomorrow in Houston and Corpus Christi, Plus Extended Hours at 1-800-DIABETES Call Center Through Next Week
The first shipment of more than 3,750 pounds of diabetes supplies will arrive in the Houston area the evening of Friday, September 1.

August 31, 2017
Additional 3,000 Pounds of Diabetes Supplies Shipped to Devastated Houston and Surrounding Communities
An additional 3,000 pounds of donated diabetes supplies have been shipped and are due to arrive early Labor Day week.

August 29, 2017
American Diabetes Association, JDRF and Insulin for Life Respond to Catastrophic Flooding Due to Hurricane Harvey in Texas
More than 3,750 pounds of donated diabetes supplies have been shipped to people with diabetes affected by Hurricane Harvey.

August 28, 2017
American Diabetes Association and JDRF Partnering to Provide Emergency Support for People with Diabetes Impacted by Hurricane Harvey
The groups have joined forces to help those affected access the information, medical supplies and support they need to effectively manage their diabetes during this crisis.

August 22, 2017
American Diabetes Association Issues Updated Diabetes and Hypertension Position Statement
On behalf of the Association, a team of nine leading diabetes experts has reviewed and updated guidelines on the assessment and treatment of hypertension in people with diabetes, including a newly added pictorial algorithm for the treatment of confirmed hypertension in people with diabetes.

August 15, 2017
American Diabetes Association Deeply Concerned with Recent Prescription Drug Formulary Trends
The Association is deeply concerned with recent trends in prescription drug formulary designs that result in frequent changes in drug coverage for individuals with diabetes. As pharmacy benefits managers (PBMs), insurers and employers finalize their 2018 formulary lists, the Association urges them to focus on continuity of care for individuals with diabetes.

July 28, 2017
American Diabetes Association® and American Association of Diabetes Educators Issue 2017 National Standards for Diabetes Self-Management Education and Support
The American Diabetes Association (Association) and the American Association of Diabetes Educators (AADE) are publishing the “2017 National Standards for Diabetes Self-Management Education and Support” (Standards). The detailed recommendations, which are updated regularly, will be published online on July 28, 2017, and in the September 2017 issues of Diabetes Care and The Diabetes Educator.

July 24, 2017
12 National Patient Advocacy Organizations Urge Senate to Vote “No” on Advancing ACA Repeal and to Safeguard the Health and Lives of Millions of Americans with a Bipartisan Approach to Reform
12 nonpartisan, patient and provider groups representing millions of Americans issued the following statement today ahead of the Senate procedural vote to advance repeal of the Patient Protection and Affordable Care Act (ACA).

July 24, 2017
12 National Patient Advocacy Organizations Urge Senate to Vote “No” on Advancing ACA Repeal and to Safeguard the Health and Lives of Millions of Americans with a Bipartisan Approach to Reform
12 nonpartisan, patient and provider groups representing millions of Americans issued the following statement today ahead of the Senate procedural vote to advance repeal of the Patient Protection and Affordable Care Act (ACA).

July 18, 2017
15 national patient advocacy organizations urge Congress to oppose the ACA repeal and take a bipartisan approach to reform
15 nonpartisan patient and provider groups representing millions of Americans issued the following statement today on the Senate’s proposal to repeal the Affordable Care Act (ACA).

July 18, 2017
American Diabetes Association Concurs with CDC’s Call for Continued Urgency to Decrease the Burden of Diabetes
The American Diabetes Association urges renewed attention to and investment in stemming the diabetes epidemic, following the release of the Centers for Disease Control and Prevention’s (CDC) National Diabetes Statistics Report, 2017. The new report reviewed 2015 data to confirm more than 114 million Americans have diabetes or prediabetes.

July 14, 2017
Mental Health Provider Diabetes Education Program, a Joint Initiative of the American Diabetes Association and the American Psychological Association, Receives Nearly $1 Million Grant from the Helmsley Charitable Trust
In collaboration with the American Psychological Association, the American Diabetes Association’s first Mental Health Provider Diabetes Education Program, which was launched last month, has received an $839,000 grant from The Leona M. and Harry B. Helmsley Charitable Trust to support the program.

June 23, 2017
American Diabetes Association Urges Senators to Vote Against Proposed Health Care Legislation
The American Diabetes Association has grave concerns about the impact the draft Senate health care bill will have on people with diabetes. Individuals with diabetes need access to continuous health care to effectively manage their disease and to prevent dangerous and costly complications.

June 13, 2017
SGLT2 Inhibitors are Associated with Reduced Cardiovascular Disease for Patients with Type 2 Diabetes
A new class of medication, known as sodium-glucose transporter-2 (SGLT2) inhibitors, is associated with lower rates of death and hospitalization for heart failure when used to treat patients with type 2 diabetes, both with or without existing cardiovascular disease, and regardless of the specific SGLT2 inhibitor used, according to a study, “Hospitalization for Heart Failure and Death in New Users of SGLT2 Inhibitors in Patients With and Without Cardiovascular Disease—CVD-REAL Study.”

June 13, 2017
Daily, Long-Acting Oral Insulin Tablet Provides Comparable Glycemic Control to Insulin Glargine Injection in Patients with Type 2 Diabetes
A long-acting, oral insulin tablet has been found to safely improve glycemic control as effectively as the common, injected insulin glargine in people with Type 2 diabetes, according to the study, “Efficacy and Safety of Oral Basal Insulin: Eight-Week Feasibility Study in People with Type 2 Diabetes (T2DM).”

  • Last Reviewed: November 18, 2013
  • Last Edited: May 1, 2017